Midgard Science
T

Tacalyx

Berlin, Germany tacalyx.com

From their website, Nov 2026

Work here? Claim this listing

About

Tacalyx GmbH develops novel anticancer therapeutics targeting tumor-associated carbohydrate antigens (TACAs). It is based in Berlin, Germany, and was founded in 2019 as a spin-out of the Max-Planck-Institute of Colloids and Interfaces in Potsdam.

Services

  • Antibody generation

    Generates antibodies for its TACA-targeting programs.

  • Cell-based assays

    Runs cell-based assays to support antibody drug development and pipeline work.

  • Glycobiology

    Performs glycobiology work focused on tumor-associated carbohydrate antigens.

  • Antibody and protein biochemistry

    Carries out antibody and protein biochemistry for therapeutic development.

Capabilities

Assays and studies
Antibodies · Cell-based assays · ADCs
Therapeutic areas
Cancer

Modalities and species

Modalities
Antibody · ADC

Industries served

  • Biotech

Company

Founded
2019

Locations

Based in
Berlin, Germany
Sites
Berlin, Germany · Potsdam, Germany

Contacts

Similar labs

Work here? Claim this listing